|
|
|
Vol. 12, No. 3, pp. 370-381, February 1, 1998
1 Department of Biology, McGill University, Montreal, PQ, Canada H3A 1B1; 2 Program in Cell Biology and Genetics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021 USA; 3 Department of Genetics, Case Western Reserve University, Cleveland, Ohio 44106-4955 USA
| |
Abstract |
|---|
|
|
|---|
Cdk7 has been shown previously to be able to phosphorylate and activate many different Cdks in vitro. However, conclusive evidence that Cdk7 acts as a Cdk-activating kinase (CAK) in vivo has remained elusive. Adding to the controversy is the fact that in the budding yeast Saccharomyces cerevisiae, CAK activity is provided by the CAK1/Civ1 protein, which is unrelated to Cdk7. Furthermore Kin28, the budding yeast Cdk7 homolog, functions not as a CAK but as the catalytic subunit of TFIIH. Vertebrate Cdk7 is also known to be part of TFIIH. Therefore, in the absence of better genetic evidence, it was proposed that the CAK activity of Cdk7 may be an in vitro artifact. In an attempt to resolve this issue, we cloned the Drosophila cdk7 homolog and created null and temperature-sensitive mutations. Here we demonstrate that cdk7 is necessary for CAK activity in vivo in a multicellular organism. We show that cdk7 activity is required for the activation of both Cdc2/Cyclin A and Cdc2/Cyclin B complexes, and for cell division. These results suggest that there may be a fundamental difference in the way metazoans and budding yeast effect a key modification of Cdks.
[Key Words: Drosophila; Cdk; CAK; mitosis; cell cycle]
| |
Introduction |
|---|
|
|
|---|
The orderly succession of DNA synthesis and cell division is
known to be largely regulated by the successive activity of different cyclin-dependent kinases
(Cdks) (Nigg 1995
). The activity of Cdks is regulated
by their association with positive and negative regulatory subunits,
and by multiple phosphorylation events (Morgan 1995
). Complete
activation of Cdks requires the phosphorylation of a conserved
threonine residue located within the T-loop, a substructure common to
all Cdks and many other protein kinases. In monomeric inactive Cdk
molecules, the T-loop blocks the catalytic site and hinders substrate
binding (De Bondt et al. 1993
). X-ray structural analysis of the
Cdk2/Cyclin A complex suggests that the T-loop is
displaced by cyclin binding, thereby opening up the active site for
substrate binding. Phosphorylation of the T-loop threonine then allows
full activation of the complex (Jeffrey et al. 1995
; Russo et al.
1996
). Because this threonine phosphorylation of the different Cdks is
a crucial step in their activation (Morgan 1995
), much effort has been
directed toward identifying and characterizing the kinases responsible
for this event.
An enzyme complex has been identified that is able to phosphorylate a
number of different Cdks on their activating threonine residue in vitro
and is known as Cdk-Activating
Kinase (CAK). CAK itself is a Cdk/Cyclin
complex: Cdk7/Cyclin H (Fesquet et al. 1993
; Poon et al.
1993
; Solomon et al. 1993
; Fisher and Morgan 1994
; Mäkelä
et al. 1994
). A third subunit, MAT1, has also been found to associate
with Cdk7 and cyclin H and to serve as an assembly factor (Devault et
al. 1995
; Fisher et al. 1995
; Tassan et al. 1995a
). However, unlike
most other Cdks, Cdk7 was found to be active throughout the cell cycle
with no detectable oscillation in its activity (Brown et al. 1994
;
Matsuoka et al. 1994
; Poon et al. 1994
; Tassan et al. 1994
). These
results suggest that the CAK activity of Cdk7 could be sufficient to
provide the activating Thr-161 (or equivalent) phosphorylation to all
Cdks throughout the cell cycle (Fesquet et al. 1993
; Poon et al. 1993
;
Solomon et al. 1993
; Fisher and Morgan 1994
, 1996
; Matsuoka et al.
1994
). In addition to its putative role in cell cycle regulation, Cdk7 is also able to phosphorylate the carboxy-terminal domain (CTD) of RNA
polymerase II (Pol II) as part of the TFIIH basic transcription factor
complex (Roy et al. 1994
; Serizawa et al. 1995
; Shiekhattar et al.
1995
).
What appears to be a functional as well as a sequence homolog to Cdk7
has been found in the fission yeast Schizosaccharomyces pombe
(Buck et al. 1995
; Damagnez et al. 1995
). The S. pombe
Mop1/Crk1 gene is essential and its product behaves
biochemically as a CAK. However, mutations in the S. pombe
Mop1/Crk1 do not lead to a uniform cell cycle arrest,
presumably because its activity is also required for TFIIH to regulate
the transcriptional activity of RNA Pol II (Buck et al. 1995
; Damagnez
et al. 1995
). In Saccharomyces cerevisiae, the gene product
with the highest sequence similarity to Cdk7 is Kin28. Although Kin28
was shown to be part of the TFIIH transcription factor (Feaver et al.
1994
) and to be required for the phosphorylation of the CTD of RNA Pol
II, it is not involved in the phosphorylation of Cdc28, the budding
yeast Cdc2 homolog (Cismowski et al. 1995
). The protein responsible for
CAK activity in S. cerevisiae was identified as
CAK1/Civ1 (Espinoza et al. 1996
; Kaldis et al. 1996
;
Thuret et al. 1996
). Surprisingly, CAK1/Civ1 shares only
limited sequence similarity with Cdk7 and other Cdks. The
identification of this in vivo CAK in budding yeast and the demonstration that it is not closely related to the vertebrate Cdk7 led
to the postulation that Cdk7/Cyclin H may in fact not represent a physiologically relevant CAK activity (Cimowski et al.
1995
; Espinoza et al. 1996
; Kaldis et al. 1996
; Thuret et al. 1996
).
Besides the two yeast, Drosophila has become a system of
choice for an in vivo analysis of the cell cycle (Edgar and Lehner 1996
; Follette and O'Farrell 1997
). One of its major values is that it
allows the genetic analysis of cell cycle events in a multicellular
organism. Like vertebrates, but contrary to the unicellular yeast,
Drosophila cells use distinct Cdks at the different cell cycle
transitions. Interestingly, although the activity of Cdk7 has been
shown in different systems to be constant throughout the cell cycle
(Brown et al. 1994
; Matsuoka et al. 1994
; Poon et al. 1994
; Tassan et
al. 1994
), the level of Cdc2 Thr-161 phosphorylation was shown to
oscillate during the late preblastoderm embryonic cycles (Edgar et al.
1994
). This indicates that the target site for CAK is regulated at
least during some cell cycles.
Here we report the identification of the Drosophila cdk7 gene. By creating null and temperature-sensitive mutations of Dmcdk7 we were able to analyze the in vivo molecular and cellular requirements for Cdk7. Although our analysis does not reveal a Cdk7 requirement for Cdk2/Cyclin E activity, it demonstrates that Cdk7 is required for mitosis and for the activation of Cdc2 in vivo.
| |
Results |
|---|
|
|
|---|
Isolation of the Dmcdk7 gene
We isolated a Drosophila melanogaster sequence homologous to the vertebrate cdk7 genes using a degenerate PCR-based approach. This Drosophila cdk7 gene codes for a predicted polypeptide of 353 amino acids with a calculated molecular mass of 39 kD. Drosophila and human Cdk7 proteins share 65% identity over the entire polypeptide (Fig. 1A), a sequence similarity higher than to any other Cdk. A single 1.6-kb Dmcdk7 poly(A+) RNA species is present throughout development and accumulates most strongly in ovaries and young embryos where it is probably maternally deposited (Fig. 1B).
|
DmCdk7 exhibits CAK activity in vitro
To be able to analyze the biochemical activity of DmCdk7, we raised antibodies against the DmCdk7 protein and used them to isolate the active enzyme from tissue homogenates. On immunoblots prepared from fly tissues, monoclonal antibodies raised against the full-length recombinant DmCdk7 recognize with high affinity a single polypeptide species, with a relative mobility of ~40 kD (Fig. 2A). This is the first indication that these anti-DmCdk7 antibodies react specifically with DmCdk7. The second one is that Drosophila Cdc2 and Cdk2 proteins, which both share a high degree of similarity with DmCdk7, cannot be detected in immunoprecipitates performed with anti-DmCdk7 antibodies (not shown).
|
To demonstrate that the identified Drosophila protein
possesses CAK activity, we used DmCdk7 immunoprecipitated from embryos 0-4 hr old to activate recombinant human HA-Cdk2/Cyclin
A complexes (Fisher and Morgan 1994
). HA-Cdk2/Cyclin A
is strongly phosphorylated when incubated with a DmCdk7
immunoprecipitate, indicating that DmCdk7 can act as a Cdk kinase (Fig.
2B). The DmCdk7-mediated phosphorylation of Cdk2 seems to occur
specifically at threonine residue 160. This is demonstrated by the
ability of DmCdk7 to phosphorylate the wild-type Cdk2 but not the
Cdk2T160A mutant protein (Fig. 2B). DmCdk7 also acts as a CAK
as it can stimulate the histone H1 kinase activity of
Cdk2/Cyclin A (Fig. 2B). These results confirm that
Dmcdk7 codes for a protein that exhibits CAK activity in vitro
and likely represents a functional homolog of the vertebrate
cdk7 genes.
Dmcdk7 is an essential gene
The Dmcdk7 gene is located in cytological interval 4F and
is separated by ~0.4 and 3 kb from its proximal neighbors sans
fille (snf) and deadhead (dhd),
respectively (Fig. 3). snf and
Dmcdk7 are oriented head to head. To create a Dmcdk7
null mutation, we took advantage of a P-element insertion at the
dhd locus (dhdP8). Imprecise excision of
this P-element produced a number of lethal mutations (Flickinger and
Salz 1994
). From this screen we identified a 4.4-kb deletion that
removes the entire Dmcdk7 and snf coding regions, as
well as part of the dhd gene (Fig. 3). This new deficiency is
designated Df(1)JB254.
|
To study the effects of lack of Dmcdk7 alone, the two other
genes disrupted by Df(1)JB254, snf and dhd, were
reintroduced into this deficiency background by P-element-mediated
transformation (Pw+[snf+,dhd+];
Fig. 3). To show that the Pw+[snf+,dhd+]
transgene is active, we tested its ability to complement the lethal
phenotype associated with Df(1)J210, a 3.0-kb deletion with
the same proximal breakpoint as Df(1)JB254 but that affects only the snf and dhd genes (Fig. 3; Flickinger and
Salz 1994
). Pw+[snf+,dhd+] fully rescues
the lethal phenotype of Df(1)J210 (not shown), but fails to
rescue the lethality associated with Df(1)JB254, indicating
that this chromosome lacks at least one additional essential function.
This function is Dmcdk7 because the introduction of a
wild-type Dmcdk7 gene (Pw+[Dmcdk7+]) into the
Df(1)JB254-Pw+[snf+,dhd+]
background results in complete rescue of the lethality. These results
demonstrate that Df(1)JB254 disrupts the Dmcdk7, snf, and dhd genes, that the defects caused by lack of snf
and dhd are rescued by
Pw+[snf+,dhd+], and that the absence of
Dmcdk7 results in zygotic lethality. Therefore, we refer to
animals carrying the Pw+[snf+,dhd+]
transposon in a homozygous Df(1)JB254 background as
cdk7null mutants.
Lack of zygotically expressed cdk7 results in death before or
soon after the initiation of pupation. cdk7null
animals often remain in a larval state, noticeably longer that their
cdk7+ siblings and, under optimal conditions, up to 50% of
the mutant larvae form a puparium, the remaining die as larvae.
cdk7null larvae exhibit defects consistent with a
disruption of mitotic activity. In cdk7null animals,
the imaginal discs fail to proliferate and do not reach their normal
size, whereas the polyploid tissue, which proceeds through replicative
S-phases without mitosis, appear normal (not shown). This phenotype
resembles the one seen in loss-of-function cdc2 mutants (Stern
et al. 1993
).
A temperature-sensitive allele of Dmcdk7
To be able to study the requirements for cdk7 activity in
different tissues and at different times during development, we created
a temperature-sensitive allele. Temperature-sensitive mutations in the
related cdc2 and Mek (Carr et al. 1989
; Hsu and Perrimon 1994
; Sigrist et al. 1995
) suggested that substituting the
conserved proline residue 140 for a serine was likely to confer temperature sensitivity to cdk7. Therefore, we introduced this mutation into cdk7 by site-directed mutagenesis, and
reintroduced the modified gene into flies. Animals carrying a
cdk7+ transgene in the cdk7null
background were found to be 100% viable at all temperatures tested, whereas those carrying the cdk7P140S allele in the
null background proved to be fully viable at 18°C but not viable at
27°C or above. These results demonstrate that the P140S mutation
results in a temperature-dependent inactivation of cdk7. Flies
carrying only the cdk7P140S transgene as a source of
Cdk7 protein therefore will be referred to as cdk7ts
mutants.
After transfer of mutant mothers to the restrictive temperature, many of the embryos laid during the first 36 hr will eclose as larvae. Most of the embryos that fail to eclose during that period exhibit defects late in development. Mutant embryos exhibit gradually earlier developmental arrest to a point where the embryonic nuclear division program fails to be initiated (data not shown).
When immunoprecipitated Cdk7P140S is used in CAK assays, a significant amount of activity is still present in embryos from females kept at the restrictive temperature for 1 day. Some activity can still be detected after 2 days at the restrictive temperature (data not shown). Similarly, the Cdk7P140S protein fails to be inactivated rapidly in vivo by incubation at high temperature (Fig. 4A). We observe a similar failure to inactivate the DmCdk7 protein in vitro after immunoprecipiation (data not shown). What then is the basis of the temperature sensitivity of cdk7ts? Embryos and ovaries isolated from Cdk7ts animals kept at the restrictive temperature show a progressive reduction of Cdk7 protein levels with time (Fig. 4B, see also Fig. 7, below).
|
Taken together, these data suggest that the P140S mutation interferes
with the stability of the mutant protein synthesized at the restrictive
temperature, whereas the mutant protein synthesized at the permissive
temperature retains significant activity until turned over. The
described properties of the P140S mutation can explain the existence of
a lag phase between the shift of temperature-sensitive mothers to the
restrictive temperature and the appearance of the mutant phenotype in
embryos (see below). Similar lag phases have also been observed, for
example, before cell cycle arrest occurs in the cak1-22 mutant
of S. cerevisiae (Kaldis et al. 1996
).
Loss of either cdk7 or cdc2 causes similar cell proliferation defects
Like their cdk7+ siblings, mutant adults allowed to develop at the permissive temperature can live for >40 days after transfer to the restrictive temperature. The production of gametes, however, stops in cdk7ts animals as females transferred to the restrictive temperature cease to lay eggs after 3-4 days as a result of compromised cell division in the germ line and supporting somatic tissue.
In Drosophila, the ovary consists of a number of tube-like
structures called ovarioles at the tip of which two to three
mitotically active germ-line stem cells continuously divide. The
asymmetric division of a stem cell gives rise to another stem cell and
a cystoblast that then goes through four incomplete mitotic divisions, resulting in a cyst of 16 germ cells connected to each other by cytoplasmic bridges (for review, see Spradling 1993
). As the 16-cell cyst moves posteriorly down the ovariole, it becomes enveloped by a
continuous monolayer of somatic follicle cells that are also supplied
by dividing stem cells (Fig. 5A; Margolis and Spradling 1995
). When pupae are transferred to the restrictive
temperature, viable cdk7ts mutant adults continue to
eclose for up to 3 days after the temperature shift to 29°C. These
animals exhibit normal adult viability when kept at the restrictive
temperature, but the mitotically active tissues exhibit progressively
stronger defects with increasing time spent at 29°C. When females
eclose shortly after transfer to 29°C, the first abnormality that is
observed in cdk7ts ovaries is the depletion of the
somatic follicle cells (Fig. 5C,D). A rapid depletion of follicle cells
is predicted to occur if cell division is compromised as each daughter
of the follicle stem cells must divide approximately nine times to
produce the 1200 follicle cells surrounding each germ-line cyst
(Mahowald and Kambyselis 1980
; Margolis and Spradling 1995
). The
depletion of follicle cells in the cdk7ts mutant
shows that cdk7 is required for mitotic division of these somatically derived cells. After the reduction in the number of follicle cells surrounding each egg chamber, the effect on the mitotic
activity of the germ line becomes apparent when cysts are found that
possess fewer than the normal number of 16 germ cells (Fig. 5D,E).
|
Cyclin E was shown previously to function during endoreplication of
polyploid tissues (Sauer et al. 1995; Lilly and Spradling 1996
), and
its activity is thought to be mediated through the activation of Cdk2
(Knoblich et al. 1994
; Sauer et al. 1995). Therefore, we were surprised
that although cell proliferation is arrested completely in
cdk7ts ovaries, the capability of these cells to
endoreplicate their DNA is not affected (Fig. 5E-G). This result may
suggest that the activity of Cdk2 is not affected by loss of
cdk7 activity.
If Cdk7 is required specifically for mitosis, we would expect the
ovarian phenotype resulting from lack of cdk7 to be similar to
the one resulting from lack of cdc2. Therefore, we analyzed the cdc2 phenotype using the temperature-sensitive transgene
Dmcdc2A171T (Sigrist et al. 1995
). Females carrying
two copies of this temperature-sensitive allele in the
Dmcdc2B47 background showed a rapid depletion of
follicle cells when transferred to the restrictive temperature after
eclosion (Fig. 5H). This depletion of follicle cells is identical to
the one observed in cdk7ts ovaries. Also, as noted
for the cdk7ts mutant ovaries, mitotic proliferation
of the germ line stops but the capacity of the germ-line cells to
replicate their DNA is not affected by the loss of cdc2
activity (Fig. 5J). Polyploidization of the germ cells usually occurs
only when the mitotic division program is terminated and the 16-cell
cyst is formed. In both cdc2 and cdk7 mutants the
polyploidization of the germ line occurs prematurely (Fig. 5J,K).
Because Cdc2 mediates this block of endoreplication in mitotic tissues
(Hayashi 1996
), these results also suggest that the premature
endoreplication observed in cdk7 mutant ovaries may be
attributable to lack of Cdc2 activity.
Cyclin levels are not reduced in cdk7ts mutant embryos
Because Cdk7 has also been implicated in the phosphorylation the
CTD of RNA Pol II as part of the TFIIH complex (Roy et al. 1994
;
Akoulithchev et al. 1995
; Serizawa et al. 1995
; Shiekhattar et al.
1995
), the cell cycle arrest observed in the cdk7 mutants could be an indirect result of reduced RNA Pol II activity, which in
turn would result in low cyclin levels (Cismowski et al. 1995
). To
determine whether reduced cdk7 activity results in a decrease in cyclin levels, the amount of the different cyclins present in the
mutant and wild-type embryos was determined by immunoblot (Fig.
6). The level of all three cyclins is high in embryos
from cdk7ts parents during stages when they are also
present at high levels in wild-type embryos. These observations
indicate that the lack of cdk7 does not cause a noticeable
reduction in cyclin levels. Cyclins A and B are expressed uniquely in
mitotically active cells (Lehner and O'Farrell 1990
). In total lysates
from embryos at different stages of development, the level of mitotic
cyclin proteins is greatly reduced in later development (Lehner and
O'Farrell 1989
; Edgar et al. 1994
). The high level of Cyclins A and B
still observed in cdk7ts embryos aged >6 hr (Fig.
6) is attributable to the fact that these embryos arrested development
at a stage when mitotic cyclin levels are still high. Another
observation suggesting that transcription in general is not disrupted
is the fact the germ-line cells can still endoreplicate their DNA in
mutant cdk7ts ovaries. Endoreplication has been
proposed to require the pulse transcription of cyclin E in embryonic
tissues (Sauer et al. 1995), and presumably also in the ovary (Lilly
and Spradling 1996
).
|
cdk7 mutant embryos are deficient in physiological CAK activity
To test whether cdk7 is essential for CAK activity, we incubated cdk7ts animals at the restrictive temperature for different amounts of time and measured the CAK activity in total cell lysates from their embryos. A gradual reduction of CAK activity, down to background level, was observed (Fig. 7A,B). This indicates a genetic requirement for cdk7 for most or all of the cellular CAK activity that can be measured in vitro. Because immunodepletion of Cdk7 protein from embryonic homogenates can effectively eliminate CAK activity from wild-type extracts (Fig. 7C,D), it can be concluded that the Cdk7 protein itself provides all of the measurable CAK activity in Drosophila embryos.
|
If Cdk7 also acts in vivo as a CAK, we would expect levels of Cdk
T-loop phosphorylation and Cdk activity to be reduced in cdk7
mutant tissues. Therefore, we isolated different
Cdk/Cyclin complexes from mutant and wild-type embryos
using antibodies directed against Cyclins A, B, and E. In
Drosophila, Cyclin A (as well as Cyclin B) associates uniquely
with Cdc2 and not with Cdk2 (Knoblich et al. 1994
; data not shown).
Although Cyclin A can be precipitated equally from either wild-type or
mutant embryos, the amount of Cdc2 protein recovered in the Cyclin A
immunoprecipitates from mutant embryos is severely decreased (Fig.
8A). In both wild-type and mutant embryos, only the
fast migrating isoform of Cdc2 can be found associated with Cyclin A in
a stable complex (Fig. 8B). This indicates that Cdk7 activity is
required for the formation of a stable Cdc2/Cyclin A
complex in vivo. On the contrary, Cdc2 can still form a stable complex
with Cyclin B in cdk7 mutant embryos, but the amount of
Thr-161 phosphorylated isoform of Cdc2 associated with Cyclin B is
reduced (Fig. 8B). The addition of recombinant Cdk7/Cyclin H to the mutant extracts before
immunoprecipitation results in an increase in the amount of fast
migrating isoform of Cdc2, confirming its identity as T-loop
phosphorylated (Fig. 8B).
|
After immunoprecipitation from both wild-type and
cdk7ts embryos, the kinase activity toward histone
H1 of Cdc2/Cyclin A, Cdc2/Cyclin B, and
Cdk2/Cyclin E complexes was measured. Although the total amount of Cdc2 associated with Cyclin B is similar in both mutant and
wild-type embryos (Fig. 8D), the Cdc2/Cyclin B complex
isolated from mutant embryos is less active than the one isolated from wild-type embryos (Fig. 8D). This loss of activity correlates with the
observed decrease in Thr-161 phosphorylation of Cdc2 (Fig. 8B). If the
reduction in activity of Cyclin B-bound Cdc2 isolated from
cdk7ts embryos is attributable uniquely to reduced
Thr-161 phosphorylation, normal activity should be restored by
treatment of this complex with CAK. To test this, the Cyclin B
immunoprecipitates were incubated with active human recombinant
Cdk7/Cyclin H after the initial measurement of the
histone H1 kinase activity. This treatment results in the restoration
of the activity (Fig. 8D) and Thr-161 phosphorylation (Fig. 8B) of the
Cdc2 isolated from mutant embryos to a level equivalent to the one
isolated from wild-type embryos. Therefore, it appears that the major
reason why the activity of the Cyclin B-bound Cdc2 is lower in
cdk7 mutant embryos (as compared to the control) is that this
Cdc2 is hypophosphorylated on Thr-161. These results indicate that
cdk7ts embryos are deficient in physiological CAK
activity. The slight delay that is observed between the time at which
there is apparently no active Cdk7 protein remaining (Fig. 7) and the
loss of Cdc2, Thr-161 phosphorylation (and the appearance of early
arrest phenotype) may be attributable to the fact that Cdc2 is
phosphorylated maternally starting from mid-oogenesis. Therefore, this
pool of active Cdc2 must be used up before the effect of lack of Cdk7
can be clearly observed. In the wild-type situation, Cdc2 Thr-161 does
not appear to be significantly dephosphorylated until nuclear cycle 11 (Edgard et al. 1994
).
In contrast to the above findings, the histone H1 kinase activity of the Cdk2/Cyclin E complex, as well as the level of Thr-163 (equivalent to Thr-160 in mammalian Cdk2) phosphorylation of Cdk2 are not affected significantly in mutant extracts as compared to wild type (Fig. 8E).
| |
Discussion |
|---|
|
|
|---|
Cdk7 has been isolated previously as a Cdk-activating kinase
(Fesquet et al. 1993
; Poon et al. 1993
; Solomon et al. 1993
; Fisher and
Morgan 1994
; Mäkelä et al. 1994
), and as a CTD kinase as
part of the TFIIH basic transcription factor complex (Roy et al. 1994
;
Akoulichev et al. 1995
; Ossipow et al. 1995
; Serizawa et al.
1995
; Shiekhattar et al. 1995
; Adamczewski et al. 1996
). Although
the concept that Cdk7 is involved in transcriptional regulation has
received general acceptance, thus far there has been no satisfying
demonstration that Cdk7 can also act as a CAK in vivo (for review, see
Fisher and Morgan 1996
; Nigg 1996
). With the analysis of the
Drosophila cdk7 gene, we set out to clarify the cell cycle
requirements for cdk7 in vivo in a multicellular organism.
cdk7 is required for mitotic proliferation
In addition to sharing a high degree of sequence similarity with
vertebrate cdk7 genes, the Drosophila gene we have
isolated in this study codes for a protein that can phosphorylate and
activate Cdk2 in vitro. The terminal phenotype of the
cdk7null mutant is similar to the strongest
loss-of-function cdc2 mutant: death before or during pupation
with little imaginal tissue (Stern et al. 1993
). A phenotype now
considered a hallmark of genes required for mitotic proliferation
(Gatti and Baker 1989
).
The creation of a temperature-sensitive allele of cdk7 allowed
us to further strengthen the possible in vivo link between cdc2 and cdk7. The temperature-dependent inactivation
of the cdk7ts allele in the ovary results in the
rapid depletion of the somatic follicle cells, which need to be
replenished continuously from a mitotically active population of stem
cells (Margolis and Spradling 1995
). Proliferation of the germ line is
also disrupted in cdk7ts mutants, resulting in the
formation of cysts with fewer than the normal complement of 16 cells.
We found these phenotypes to be very similar to the
temperature-sensitive ovarian cdc2 phenotype we have described
in this study. Similar mitotic defects in the ovary were reported
recently using a different allele of cdc2 (Reed and Orr-Weaver
1997
). These results are consistent with a model whereby Cdk7 acts in
the same pathway as Cdc2 in promoting cell division.
The CAK in cdk7
In cdk7 mutant embryos, the level of Thr-161
phosphorylation and activity of the Cyclin B-bound Cdc2 is reduced, and
both can be restored by incubation with purified
Cdk7/Cyclin H (Fig. 8). This indicates that the major
difference between Cdc2 isolated from wild-type and cdk7
mutant embryos is the extent of Thr-161 phosphorylation. Therefore,
Cdk7 is essential for in vivo CAK activity. Although
Cdc2/Cyclin B complexes form normally in
cdk7ts mutant embryos, Cdc2 and Cyclin A fail to
form a stable complex in the cdk7 mutant. This is likely
attributable to the fact that this event requires the phosphorylation
of Cdc2 on Thr-161, as even in the wild type only the phosphorylated
form is associated with Cyclin A (Fig. 8). These in vivo results
correlate well with the finding that human Cdc2 needs to be
phosphorylated by CAK to form a stable complex with Cyclin A in vitro,
whereas stable Cdc2/Cyclin B and
Cdk2/Cyclin E complexes can form in the absence of
Thr-161 (or 160) phosphorylation (Desai et al. 1995
). The
Cdc2/Cyclin A complex seems to be more sensitive to a
reduction in CAK activity than the Cdc2/Cyclin B complex,
as the loss of Cyclin A binding occurs more rapidly than the reduction
of Thr-161 phosphorylation of Cyclin B-associated Cdc2.
Because Cdk7/Cyclin H is able to phosphorylate many
Cdk/cyclin complexes in vitro, it was postulated that a
single CAK could be responsible for the activation of all the
different Cdks acting throughout the cell cycle (Fisher and Morgan
1994
). This idea was further reinforced by the observation that Cdk7
activity is apparently present throughout the cell cycle (Brown et al.
1994
; Matsuoka et al. 1994
; Poon et al. 1994
; Tassan et al. 1994
).
Therefore, we were intrigued by the continuing DNA synthesis observed
in the germ cells of cdk7ts mutant ovaries. Two
explanations could account for the lack of effect on endoreplication:
(1) Cdk2 is not involved in DNA synthesis during endoreplication. This
possibility cannot be excluded formally as no mutant phenotype has been
described so far for cdk2. (2) Cdk2 may not require threonine
phosphorylation for its DNA synthesis-promoting activity during
endoreplication.
Because no effect on the levels of Cdk2 Thr-163 phosphorylation or activity could be detected in cdk7 mutant embryos, it is possible that the threonine-phosphorylated form of Cdk2 is highly stable or requires a lower threshold of CAK activity than Cdc2. Alternatively Cdk2 may be activated by a CAK different from Cdk7. But as it appears that all of the measurable embryonic CAK activity in Drosophila can be eliminated either genetically by the inactivation of cdk7 or biochemically by immunodepletion of Cdk7, if such a second CAK exists, its biochemical characteristics such as substrate specificity or solubility would have to be very different from that of either Cdk7 or CAK1. Or it would have to be absent from the stages analyzed. Figure 9 summarizes the sum of accumulated data on CAKs and TFIIH kinases in yeasts and metazoans.
|
CAK in yeast and metazoan: a question of evolution?
It is impossible to demonstrate with absolute certitude that Cdk7
phosphorylates Cdc2 in vivo. But the evidence to that effect is
overwhelming; Cdk7 acts as an excellent CAK in vitro and CAK activity
can be entirely depleted from a cellular extract with Cdk7 antibodies
(this study; Fesquet et al. 1997
). The loss of cdk7 gene
function results in the abolition of in vivo CAK activity and reduced
Cdc2 T-loop phosphorylation and activity (this study) and has a
phenotype identical to that of loss of cdc2 (this study). These observations leave little room for an explanation other than that
Cdk7 is active as an in vivo CAK.
The basic components of the cell cycle regulatory machinery are, for the most part, shared by both yeast and higher eukaryotes. It has been shown in numerous cases that the mechanisms, as well as molecules, that regulate the cell cycle in yeast are usually also conserved in higher eukaryotes. Therefore, it may come as a surprise that yeast and metazoans would use entirely different molecules, such as Cdk7 and CAK1, to carry out identical enzymatic reactions in such a basic mechanism as the activating phosphorylation of Cdks. Perhaps even more surprising is that a "complex" multicellular organism would use a single enzyme to carry out two very distinct functions, whereas the apparently much simpler unicellular yeast would use two different ones. However, the analysis of all the data obtained in this study and previously with Cdk7, Kin28, and CAK1 clearly point into this direction.
Now that the sequence of the whole genome of S. cerevisiae
is known, it is clear that of all yeast proteins Kin28 is the one with
the highest sequence similarity to Cdk7. At the functional level, both
proteins can be found as subunits of TFIIH and are known to interact
physically with related cyclin-like molecules, Cdk7 with Cyclin H
(Fisher and Morgan 1994
; Mäkelä et al. 1994
) and Kin28 with
Ccl1 (Valay et al. 1993
). Both Cdk7 and Kin28 can use the CTD of RNA
Pol II as substrate in vitro. From these data it seems clear that Cdk7
and Kin28 are not only related by sequence, but also carry out similar
cellular functions in both organisms. However, there is a major
difference between the two molecules; Cdk7 is a very efficient CAK in
vitro, whereas Kin28 has no detectable CAK activity either in vitro or
in vivo (Cismowski et al. 1995
; Valay et al. 1995
). The present work
underlines another major difference between Cdk7 and Kin28, this time
at the level of a genetic requirement. We clearly demonstrate that
cdk7 activity is required for the production of CAK activity
in vivo, whereas Kin28 is not (Cismowski et al. 1995
; Valay et
al. 1995
). Our failure to detect a defect in transcription in
cdk7 mutants could mean that the Cdk7ts protein
persists longer as part of TFIIH, which may stabilize its activity.
Alternatively, these observations may indicate that Cdk7 activity is
not essential for transcription under our experimental conditions. For
example, it may be that a different protein acts redundantly with Cdk7
as a CTD kinase. At least two other Cdks are known to be able to act as
CTD kinase in human cells, Cdk8 (Tassan et al. 1995b
) and Cdk9(PITLARE)
(Jones 1997
).
Evidently unicellular organisms have continued to evolve just like metazoans did. Maybe it was advantageous for S. cerevisiae to use two distinct proteins to carry out functions for which only one has remained necessary in other organisms. The emergence of CAK1 may then have lead to the evolution of Kin28, a Cdk7 that has lost its ability to act as a CAK. In this context it would be interesting to know whether metazoans have a CAK1 homolog. Thus far none have been reported, but whether there is or is not a CAK1 homolog in multicellular organisms will be answered only with its discovery or the completion of the sequencing of a metazoan genome.
| |
Materials and methods |
|---|
|
|
|---|
DNA cloning and deficiency analysis
The described Dmcdk7 cDNA was isolated during a screen
for protein kinases (Larochelle and Suter 1995
). Library screening, nucleic acid hybridizations, and sequencing were done according to
standard protocols. Deletions produced by the imprecise excision of the
dhdP8 P-element (Flickinger and Salz 1994
) were
tested by Southern hybridization using a Dmcdk7 cDNA probe. To
map precisely the genomic region deleted by the Df(1)JB254
deficiency, PCR amplifications were carried out using primers cdk7-P1
(5
-ACAACTCATGTTGGGTGGCG-3
) in the Dmcdk7 3
UTR
region, and dhd-P5 (5
-GGATTGCTGCTTACGCCTTC-3
) followed by
sequencing.
Site-directed mutagenesis and transformation constructs
The mutagenic primer used to create the temperature-sensitive
mutation was P140S 5
-CGCGATTTGAAGTCCAACAATTTGC-3
. The
rescue construct for dhd and snf genes was
constructed by cloning a 3.7-kb StuI-EcoRI fragment
containing ~25% of the Dmcdk7 and the entire snf
genomic region into pBluescript KS
SmaI-EcoRI
sites. A 4.8-kb XhoI fragment containing the dhd gene
was then added at a single genomic XhoI site within the 3.7-kb
StuI-EcoRI fragment. A 5.5-kb XbaI-BamHI fragment containing both entire
snf and dhd genomic regions was then cloned into the
pCaSpeR transformation vector.
Genetics and fly stocks
The P-element excision screen that gave rise to
Df(1)JB254 is described in Flickinger and Salz (1994)
. The
Dmcdk7null chromosome was constructed by recombining
an X chromosomal insert of Pw+[snf+,dhd+]
with w Df(1)JB254. Dmcdk7ts were obtained by
crossing males carrying a Sb Pw+[Dmcdk7-P140S]
third chromosome to Dmcdk7null females. The females
used for these crosses were either w Df(1)JB254 Pw+[snf+,dhd+]/ w
Df(1)JB254 Pw+[snf+,dhd+];
+/+; Pw+[Dmcdk7 P140S]
Sb/+ for analysis of the ovarian phenotype or
w Df(1)JB254
Pw+[snf+,dhd+]/ w
Df(1)JB254 Pw+[snf+,dhd+];
+/+; Pw+[Dmcdk7
P140S/ Pw+[Dmcdk7
P140S] to obtain cdk7ts embryos.
The Dmcdc2 alleles B47 and the temperature-sensitive Dmcdc2ts4x: w/w;
Pw+[cdc2A171T],
cdc2B47/
Pw+[cdc2A171T], cdc2B47;
Pw+[cdc2A171T]/
Pw+cdc2A171T] lines have been decribed before (Stern et
al. 1993
; Sigrist et al. 1995
). cdc2ts flies used in
this study were obtained by crossing Dmcdc2ts4x to
+/+; cdc2B47/SM6A;
+/+. w/+;
Pw+[cdc2A171T],
cdc2B47/cdc2B47;
Pw+[cdc2A171T]/+ were used for
phenotypic analysis of the ovary.
Antibodies and protein blotting
Anti-DmCdk2 (Cdc2c) and anti-Cyclin A and B antibodies were
provided by C. Lehner (Bayreuth), anti-DmCdc2 and anti-PSTAIR antibodies by P. O'Farrell [University of California, San Francisco (UCSF)] and M. Yamashita (Hokkaido University, Sapporo, Japan), respectively. Recombinant DmCdk7 protein was produced by cloning the
entire coding region of the Dmcdk7 cDNA into the
NdeI-BamHI sites of the pET-3 (pAR) protein
expression vector. BALB/c mice were immunized three times
at 5-week interval using 50 µg of protein emulsified in TiterMax
synthetic adjuvant (CytRx corp., Atlanta, GA). Screening of the
hybridoma lines was carried out by ELISA using a MBP-DmCdk7 fusion
protein (New England Biolabs), and immunobloting using ovarian protein
extracts from Drosophila. The antibodies used in this study
(19E7 and 20H5) recognize a single polypeptide species with high
affinity. For immunoblotting, standard SDS-PAGE was used except for the
separation of the Thr-161 phosphorylated and nonphosphorylated form of
Cdc2 (Fig. 8A,B). For this purpose the acrylamide stock solution used
was 30% T:1.67% C using Piperazine di-acrylamide (Bio-Rad) as
crosslinker (Kumagai and Dunphy 1995
).
Ovary staining
Ovaries were dissected in Ringer's solution and fixed for 20 min. in 200 µl of 4% paraformaldhehyde in PBS + 0.2% Tween 20, 20 µl of DMSO, and 600 µl of n-heptane. Washed several times in PBST, and stained for 1 hr with 10 µg/ml of Hoechst 33258 in PBST.
Kinase assays
For CAK assays on immunoprecipitates, ~50-200 µl embryos
(or 20-100 pairs of ovaries) were homogenized in 1.0 ml of HoB buffer [25 mM HEPES (pH 7.4); 150 mM NaCl, 5 mM
NaF; 1 mM EDTA, 1 mM DTT, 0.1 mM
Na3VO4, 0.1% Triton X-100, 2 µg/ml of aprotinin; 2 mM PMSF, 1 µg/ml of leupeptin]. The homogenate was centrifuged at 14,000 rpm for 20 min and the cleared supernatant incubated with 20 µl of protein G plus agarose (Calbiochem) previously reacted with
monoclonal anti-DmCdk7 19E7. The immunoprecipitate was washed three
times with the same buffer and three times with HD [25 mM HEPES (pH 7.4), 1 mM DTT]. CAK activity was measured by
adding 0.6 µg of recombinant human HA-Cdk2/Cyclin A
(a gift from H. Espinoza and D.O. Morgan, University of California, San
Francisco) in 20 µl [25 mM HEPES (pH 7.4), 10 mM MgCl2; 50 µM ATP; 10 µCi
[
-32P]ATP (3000 mCi/mmole), 1 mM DTT] and incubated at room temperature for 20 min. The
supernatant was removed from the immunoprecipitate and boiled twice in
one volume of sample buffer. For direct assessment of HA-Cdk2
phosphorylation the protein was run over a 10% polyacrylamide gel and
the dried gel exposed for 2 hr with intensifying screens. For direct
detection of Cdk2, samples were transferred to nitrocellulose and the
HA-Cdk2 protein detected with anti-HA (12CA5 or HA.11) antibody
(BabCO) and SuperSignal (Pierce).
For histone H1 kinase assays on Cdk/cyclin complexes, 50 µl of control or mutant embryos (2-6 hr old) were homogenized in 300 µl of HoB and incubated 3 hr with 15 µl of protein
G-agarose previously reacted with monoclonal anti-cyclins A, B, or E. The immunoprecipitates were washed three times with HoB, three times with HDS buffer [25 mM HEPES (pH 7.4), 1 mM DTT,
150 mM NaCl] and once with HD buffer. The immunoprecipitates
were incubated with 30 µl of histone H1 kinase mix (3.0 µg of
histone H1 (Boehringer), 25 mM HEPES (pH 7.4), 10 mM MgCl2, 1 mM DTT, 50 mM NaCl,
50 µM ATP, 10 µCi [
-32P]ATP) and
incubated at room temperature for 20 min. The reaction mixture was
removed from the immunoprecipitate and boiled in one volume of SDS
sample buffer. For reactivation by recombinant CAK, the
immunoprecipitates from the previous step were washed several times
with HoB and HD buffers as above and then incubated with 50 ng of
recombinant human Cdk7/Cyclin H in 20 µl [25
mM HEPES (pH 7.4), 10 mM MgCl2, 1 mM DTT, 0.1 mM ATP] for 20 min. The beads were
subsequently washed with HoB and HDS to remove the CAK. Finally, the
histone H1 kinase activity was remeasured as described above.
For CAK assay on total lysates, samples (embryos or ovaries) were
homogenized in EB buffer [10 mM Tris (pH 7.5), 80 mM Na
-glycerophosphate, 20 mM EGTA, 15 mM MgCl2, 2 mM
Na3VO4, 1 mM benzamidine, 1 mM
meta-bisulfite, 2 µg/ml of aprotinin, 2 mM
PMSF, 1 µg/ml of leupeptin] (Edgar et al. 1994
). The
protein concentration in each sample was measured using Bradford
protein assay (Bio-Rad) with BSA as standard, and the protein
concentration in the lysates adjusted to ~30
µg/µl. Samples of 10 µl were mixed with 10 µl of assay mix [25 mM HEPES (pH 7.4), 10 mM
MgCl2, 0.1 mM ATP, 10 µCi of
[
-32P]ATP (3000 mCi/mmole), 1 mM DTT, 0.1 µg of HA-Cdk2/Cyclin A]. The
reaction was stopped after 25 min by the addition of 500 µl of
HoB + 20 mM EDTA. HA-Cdk2 was immunoprecipitated using
anti-HA antibodies/protein G-agarose and the activity of
the precipitated HA-Cdk2/Cyclin A complexes was assayed
on histone H1 as described above. Quantitative data were obtained using
a Fujix BASS 2000 TR PhosphorImager.
| |
Acknowledgments |
|---|
We thank Drs. C. Lehner for anti-Cdk2, cyclins A and B antibodies, and for cdc2 fly stocks, P. O'Farrell for the anti-Cdc2 Ab, H. Richardson for the anti-Cyclin E Ab, and M. Yamashita for anti-PSTAIR Ab, D.O. Morgan and H. Espinoza for HA-Cdk2/Cyclin A, A.R. Knights for the preparation of recombinant Cdk7/Cyclin H. Thanks to C. Cariles and J. Geiger for technical assistance, M. Miron for help with the PhosphorImager, and Anne Marcil for assistance during the preparation of anti-DmCdk7 monoclonal antibodies. We also thank Dr. D.Y. Thomas for providing laboratory space during the hybridoma screening. Thanks to Akira Nakamura and Andrew Swan for critical reading of the manuscript. Work in the H.K.S. laboratory is supported by funds form the U.S. National Science Foundation. This work is supported by funds to B.S. from the National Cancer Institute of Canada with funds from the Canadian Cancer Society and the Terry Fox Run. B.S. is a research scientist of the National Cancer Institute of Canada supported by funds from the Canadian Cancer Society.
The publication costs of this article were defrayed in part by payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 USC section 1734 solely to indicate this fact.
| |
Note |
|---|
The sequence reported in this manuscript has been deposited into GenBank (accession no. U56661).
| |
Footnotes |
|---|
Received November 7, 1997; revised version accepted December 2, 1997.
4 Corresponding author.
E-MAIL BEAT_SUTER@MACLAN.MCGILL.CA; FAX (514) 398-8051.
| |
References |
|---|
|
|
|---|